Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CPSQ | ISIN: SE0015988167 | Ticker-Symbol: 7XY
Tradegate
16.02.26 | 14:07
2,165 Euro
-2,70 % -0,060
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
SWEDENCARE AB Chart 1 Jahr
5-Tage-Chart
SWEDENCARE AB 5-Tage-Chart
RealtimeGeldBriefZeit
2,1902,26016.02.
2,2152,23516.02.
GlobeNewswire (Europe)
277 Leser
Artikel bewerten:
(1)

Swedencare AB (publ): Swedencare announces new financial targets to drive sustainable growth and market leadership

Swedencare is well positioned for continued faster than the market-growth, with a strong foundation in product innovation, channel expansion, and financial discipline. By executing this five-year strategy, the company can achieve its ambitious targets and solidify its leadership in the global pet health market. The commitment to operational excellence, strategic expansion and sustainability will ensure long-term value creation for all stakeholders.

As Swedencare moves forward, ongoing adaptation and responsiveness to industry trends, technological advancements, and evolving customer needs will be essential. The company will reinforce its collaborative approach with veterinary professionals and research partners to uncover new opportunities, while also leveraging digital transformation to optimize both customer engagement and operational efficiency. By nurturing a culture of innovation, transparency, and entrepreneurship, Swedencare aims to not only meet but exceed stakeholder expectations, ensuring resilient growth and a lasting positive impact in the pet health sector.

Financial Targets and Strategic Priorities
Swedencare has updated its financial targets for the next 5 years to reflect the current market situation, growth ambitions and commitment to shareholder value:

New Targets

  • Annual double-digit organic growth
  • Establish an Op. EBITDA margin above 26% midterm (approx. 23% Op. EBIT margin)
  • Dividend payout* of 40% of net profit, adjusted for non-operating costs
  • Net debt/EBITDA (proforma and adjusted for IFRS16) ratio below 2.0**

These targets underscore Swedencare's focus on disciplined financial management, operational efficiency, and strategic expansion.

*Swedencare will propose a dividend that takes into account the group's profit as well as it consolidation and investment needs, liquidity, and financial position.
**Subject to flexibility for acquisitions.

Chairman of the Board Statement
"Since 2014, Swedencare has evolved from a single-brand company into a diversified global pet health group, with operations in nine countries and sales across more than 70 markets.
The Board's updated financial targets underscore our focus on disciplined capital allocation, margin expansion, and sustainable above-market organic growth. Supported by a scalable operating model, strong cash generation, and prudent leverage, we believe Swedencare is well positioned to deliver attractive long-term shareholder returns in a structurally growing global pet health market."
- Håkan Svanberg, Chairman of the Board, Swedencare

CEO Statement
"Our five-year strategy is designed to position Swedencare as a global leader in pet health while delivering sustainable value for all stakeholders. By combining innovation, operational excellence, and a strong commitment to sustainability, we are confident in our ability to achieve these ambitious goals. We will continue to adapt to industry trends and invest in digital transformation to ensure we remain at the forefront of customer engagement and product development."
- Håkan Lagerberg, CEO, Swedencare

Building for the Future
In addition to these financial goals, Swedencare is continuously committed to:

  • Consistently setting internal goals that surpass external expectations
  • Continue seeking distinctive acquisitions to expand the group's presence, both in terms of geography and product offerings
  • To attract top talent and ensure high employee satisfaction

For more information, please contact:

Håkan Svanberg, Chairman of the board
Mobil: +46 (0) 70 412 77 30
Email: hakan@svanberg.io

FNCA is the company's Certified Adviser

Please visit the Company homepage www.swedencare.com

About Swedencare

Swedencare is listed on the NASDAQ First North Growth Market and also trades on the OTCQX® Best Market. We develop, produce, and sell premium products in the global and rapidly growing pet healthcare market, focusing on cats, dogs, and horses. Our extensive product portfolio includes strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, Rileys®, and ProDen PlaqueOff®, the original solution for good oral health.

With headquarters in Malmö, our products are sold in approximately 70 countries through veterinarians, pet stores, and online. Our extensive distribution network consists of subsidiaries in nine countries, along with an international network of retailers. Swedencare has experienced strong growth for several years while maintaining high profitability.

© 2025 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.